• Junot S
  • PV 270
  • Novembre 2006

Bibliographie

1 - Altman RD. Neutrophil activation: an alternative to prostaglandin inhibition as the mechanism of action for NSAIDs. Semin. arthritis rheum. 1990;19:1-5.
2 - Badid C, Chambrier C, Aouifi A, et coll. Nonsteroidal anti-inflammatory drug and angiotensin converting enzyme inhibitor: a dangerous association in postoperative period. Ann. Fr. Anesth. Reanim. 1997;16:55-57.
3 - Beale BS. Orthopedic problems in geriatric dogs and cats. Vet. Clin. North Am. Small Anim. Pract. 2005;35:655-674.
4 - Beiche F, Scheuerer S, Brune K, et coll. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Letters 1996;390:165-169.
5 - Brideau C, Van Staden C, Chan CC. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats. Am. J. Vet. Res. 2001;62:1755-1760.
6 - Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2-selective inhibition. Am. J. Med. 1999;107:65S-71S.
7 - Caulkett N, Read M, Fowler D, et coll. The analgesic effects of butorphanol and meloxicam after elective ovariohysterectomy in dogs. Vet. Anaesth. Analg. 2002;29:97-112.
8 - Deneuche AJ, Dufayet C, Goby L, et coll. Analgesic Comparison of Meloxicam or Ketoprofen for Orthopedic Surgery in Dogs. Vet. Surg. 2004;33:650-660.
9 - Doig PA, Purbrick KA, Hare JE, et coll. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis. Can. Vet. J. 2000;41:296-300.
10 - Eberhart CE, Coffey RJ, Radhika A, et coll. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994;107:1183-1188.
11 - Esteban V, Lorenzo O, Ruperez M, et coll. Angiotensin II, via AT1 and AT2 Receptors and NF-{kappa}B Pathway, Regulates the Inflammatory Response in Unilateral Ureteral Obstruction. J. Am. Soc. Nephrol. 2004;15:1514-1529.
12 - Feliers D, Duraisamy S, Barnes JL, et coll. Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II. Am. J. Physiol. Renal Physiol. 2005;288:F521-529.
13 - Fox A, Medhurst S, Courade J-P, et coll. Anti-hyperalgesic activity of the cox-2 inhibitor lumiracoxib in a model of bone cancer pain in the rat. Pain. 2004;107:33-40.
14 - Gajraj NM. The effect of cyclooxygenase-2 inhibitors on bone healing. Reg. Anesth. Pain Med. 2003;28:456-465.
15 - Gogny M, Bidon JC. Les effets indésirables des anti-inflammatoires non stéroïdiens chez les carnivores. Point Vét. 1997;28:1581-1589.
16 - Grauer GF, Rose BJ, Toolan L, et coll. Effects of low-dose aspirin and specific thromboxane synthetase inhibition on whole blood platelet aggregation and adenosine triphosphate secretion in healthy dogs. Am. J. Vet. Res. 1992;53:1631-1635.
17 - Grisneaux E, Pibarot P, Dupuis J, et coll. Comparison of ketoprofen and carprofen administered prior to orthopedic surgery for control of postoperative pain in dogs. J. Am. Vet. Med. Assoc. 1999;215:1105-1110.
18 - Griswold DE, Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med. Res. Rev. 1996;16:181-206.
19 - Harris RC, McKanna JA, Akai Y, et coll. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest. 1994;94:2504-2510.
20 - Hjelle JJ, Grauer GF. Acetaminophen-induced toxicosis in dogs and cats. J. Am. Vet. Med. Assoc. 1986;188:742-746.
21 - Holtsinger RH, Parker RB, Beale BS. The therapeutic efficacy of carprofen (Rimadyl-V) in 209 clinical cases of canine degenerative joint disease. J. Vet. Comp. Orthop. Trauma. 1992;5:140-144.
22 - Hugonnard M, Leblond A, Cadoré J-L, et coll. Evaluation et traitement de la douleur des carnivores domestiques. Point Vét. 2001;32:48-51.
23 - Juni P, Nartey L, Reichenbach S, et coll. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet 2004;364:2021-2029.
24 - Kawalek JC, el Said KR. Maturational development of drug-metabolizing enzymes in sheep. Am. J. Vet. Res. 1990;51:1736-1741.
25 - Laredo FG, Belda E, Murciano J, et coll. Comparison of the analgesic effects of meloxicam and carprofen administered preoperatively to dogs undergoing orthopaedic surgery. Vet. Rec. 2004;155:667-671.
26 - Lascelles BD, Cripps PJ, Jones A, et al. Efficacy and kinetics of carprofen, administered preoperatively or postoperatively, for the prevention of pain in dogs undergoing ovariohysterectomy. Vet. Surg. 1998;27:568-582.
27 - Lascelles BD, Cripps P, Mirchandani S, et coll. Carprofen as an analgesic for postoperative pain in cats: dose titration and assessment of efficacy in comparison to pethidine hydrochloride. J. Small Anim. Pract. 1995;36:535-541.
28 - Lefebvre HP, Toutain PL. Angiotensin-converting enzyme inhibitors in the therapy of renal diseases. J. Vet. Pharmacol. Ther. 2004;27:265-281.
29 - Lester P, Gaynor JS. Management of cancer pain. Vet. Clin. North Am. Small Anim. Pract. 2000;30:951-966, ix.
30 - Li G, Yang T, Yan J. Cyclooxygenase-2 increased the angiogenic and metastatic potential of tumor cells. Biochem. Biophys. Res. Commun. 2002;299:886-890.
31 - McCann ME, Andersen DR, Zhang D, et coll. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis. Am. J. Vet. Res. 2004;65:503-512.
32 - Majima M, Hayashi I, Muramatsu M, et coll. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol. 2000;130:641-649.
33 - Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J. Pharmacol. Exp. Ther. 1992;263:136-146.
34 - Mathews KA. Nonsteroidal anti-inflammatory analgesics. Indications and contraindications for pain management in dogs and cats. Vet. Clin. North Am. Small Anim. Pract. 2000;30:783-804, vi-vii.
35 - Mathews KA. Nonsteroidal anti-inflammatory analgesics in pain management in dogs and cats. Can. Vet. J. 1996;37:539-545.
36 - Mathews KA, Paley DM, Foster RA, et coll. A comparison of ketorolac with flunixin, butorphanol, and oxymorphone in controlling postoperative pain in dogs. Can. Vet. J. 1996;37:557-567.
37 - Mukherjee D, Nissen SE, Topol EJ. Risk of cardiovascular events associated with selective COX-2 inhibitors. J. Am. Med. Assoc. 2001;286:954-959.
38 - Nolan A, Reid J. Comparison of the postoperative analgesic and sedative effects of carprofen and papaveretum in the dog. Vet. Rec. 1993;133:240-242.
39 - Papich MG. Pharmacologic considerations for opiate analgesic and nonsteroidal anti-inflammatory drugs. Vet. Clin. North Am. Small Anim. Pract. 2000;30:815-837, vii.
40 - Perlstein TS, Gumieniak O, Hopkins PN, et coll. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004;66:1465-1470.
41 - Pibarot P, Dupuis J, Grisneaux E, et coll. Comparison of ketoprofen, oxymorphone hydrochloride, and butorphanol in the treatment of postoperative pain in dogs. J. Am. Vet. Med. Assoc.1997;211:438-444.
42 - Ricketts AP, Lundy KM, Seibel SB. Evaluation of selective inhibition of canine cyclo-oxygenase 1 and 2 by carprofen and other nonsteroidal anti-inflammatory drugs. Am. J. Vet. Res. 1998;59:1441-1446.
43 - Schwab JM, Schluesener HJ, Meyermann R, et coll. COX-3 the enzyme and the concept: steps towards highly specialized pathways and precision therapeutics? Prostaglandins leukot. essent. fat. acids. 2003;69:339-343.
44 - Slingsby LS, Waterman-Pearson AE. Postoperative analgesia in the cat after ovariohysterectomy by use of carprofen, ketoprofen, meloxicam or tolfenamic acid. J. Small Anim. Pract. 2000;41:447-450.
45 - Sorokin A. Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype. Curr. Pharm. Des. 2004;10:647-657.
46 - Tam SS, Lee DH, Wang EY, et coll. Tepoxalin, a novel dual inhibitor of the prostaglandin-H synthase cyclooxygenase and peroxidase activities. J. Biol. Chem. 1995;270:13948-13955.
47 - Taylor PM. Newer analgesics. Nonsteroid anti-inflammatory drugs, opioids, and combinations. Vet. Clin. North Am. Small Anim. Pract. 1999;29:719-735, vii.
48 - Vandaële E, Troncy E. L'AINS s'injecte avant la chirurgie mais n'est efficace qu'après. Point Vét. 2002;33:16-17.
49 - White WB, Faich G, Whelton A, et coll. Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac. Am. J. Cardiol. 2002;89:425-430.
50 - Wolfe LS. Eicosanoids: prostaglandins, thromboxanes, leukotrienes, and other derivatives of carbon-20 unsaturated fatty acids. J. Neurochem. 1982;38:1-14.
51 - Xie WL, Chipman JG, Robertson DL, et coll. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sci. U. S. A. 1991;88:2692-269.
52 - Yeary RA, Swanson W. Aspirin dosages for the cat. J. Am. Vet. Med. Assoc. 1973;163:1177-1178.


En poursuivant votre navigation sur ce site, vous acceptez l’utilisation de cookies pour vous proposer des services et offres adaptés à vos centres d’intérêts.X
Pour en savoir plus et paramétrer les cookies...